Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 12,500 shares at $27.97 ($350K) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Scheduled sale ($350k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |
| BCAX | SELL | 2026-03-05 | $602K | — | Filing → |